Design and synthesis of 1H-indazole-3-carboxamide derivatives as potent and selective PAK1 inhibitors with anti-tumour migration and invasion activities

被引:5
作者
Zhang, Mingliang [1 ]
Fang, Xiaobao [1 ]
Wang, Cong [1 ]
Hua, Yi [1 ]
Huang, Chen [1 ]
Wang, Meng [1 ]
Zhu, Lu [1 ]
Wang, Zixu [1 ]
Gao, Yuhan [1 ]
Zhang, Tianyi [1 ]
Liu, Haichun [1 ]
Zhang, Yanmin [1 ]
Lu, Shuai [1 ]
Lu, Tao [1 ,2 ]
Chen, Yadong [1 ,2 ]
Li, Hongmei [1 ]
机构
[1] China Pharmaceut Univ, Lab Mol Design & Drug Discovery, Nanjing 211198, Peoples R China
[2] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
PAK1; inhibitor; Kinase selectivity; 1H-indazole-3-carboxamide scaffold; Anti-tumour metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; P21-ACTIVATED KINASES; BIOLOGICAL EVALUATION; OPTIMIZATION; PALLADIUM; DISCOVERY; AMIDES;
D O I
10.1016/j.ejmech.2020.112517
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aberrant activation of p21-activated kinase 1 (PAK1) is associated with tumour progression, and PAK1 has been recognized as a promising target for anticancer drug discovery. However, the development of potent PAK1 inhibitors with satisfactory kinase selectivity and favourable physicochemical properties remains a daunting challenge. Herein, we identified the 1H-indazole-3-carboxamide derivatives as potential PAK1 inhibitors using a fragment-based screening approach. The representative compound 301 exhibited excellent enzyme inhibition (PAK1 IC50 = 9.8 nM) and high PAK1 selectivity toward a panel of 29 kinases. The Structure-activity relationship (SAR) analysis showed that substituting of an appropriate hydrophobic ring in the deep back pocket and introducing a hydrophilic group in the bulk solvent region were critical for PAK1 inhibitory activity and selectivity. Additionally, the hERG channel activity of 301 demonstrated its low risk of hERG toxicity. Furthermore, it significantly suppressed the migration and invasion of MDA-MB-231 cells by downregulating Snail expression without affecting the tumour growth. These results provide a new type of chemical scaffolds targeting PAK1 and suggested that 1H-indazole-3-carboxamide derivatives may serve as lead compounds for the development of potential and selective PAK1 inhibitors. (C) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Facile synthesis of new N1-alkylated 1H-indazole-3-carboxamide derivatives as potential anticancer agents: In vitro, ADMET prediction, and SAR studies
    Puri, Sachin
    Juvale, Kapil
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1269
  • [2] Design, Synthesis and Antitumor Activity of 1H-indazole-3-amine Derivatives
    Wang, Congyu
    Zhu, Mei
    Long, Xuesha
    Wang, Qin
    Wang, Zhenchao
    Ouyang, Guiping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [3] Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors
    Lin, Tingting
    Li, Jiacheng
    Liu, Liping
    Li, Yuanqing
    Jiang, Hualiang
    Chen, Kaixian
    Xu, Pan
    Luo, Cheng
    Zhou, Bing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 215
  • [4] Design, synthesis and biological evaluation of 1H-pyrazolo [3,4-d] pyrimidine derivatives as PAK1 inhibitors that trigger apoptosis, ER stress and anti-migration effect in MDA-MB-231 cells
    Zhang, Jin
    Zou, Ling
    Tang, Pan
    Pan, Dabo
    He, Zhendan
    Yao, Dahong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 194
  • [5] Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors
    Hou, Shaohua
    Yang, Xiping
    Yang, Yuejing
    Tong, Yu
    Chen, Quanwei
    Wan, Boheng
    Wei, Ran
    Lu, Tao
    Chen, Yadong
    Hu, Qinghua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 220
  • [6] Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors
    Caldarelli, Marina
    Angiolini, Mauro
    Disingrini, Teresa
    Donati, Daniele
    Guanci, Marco
    Nuvoloni, Stefano
    Posteri, Helena
    Quartieri, Francesca
    Silvagni, Marco
    Colombo, Riccardo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (15) : 4507 - 4511
  • [7] Design, synthesis and bioevaluation of 1H-indole4-carboxamide derivatives as potent poly(ADP-ribose) polymerase-1 inhibitors
    Xie, Zhouling
    Chen, Yu
    Xu, Pengfei
    Zhou, Youli
    Zhao, Qian
    Jiao, He
    Li, Zhiyu
    RSC ADVANCES, 2016, 6 (84) : 80784 - 80796
  • [8] Design, synthesis and biological evaluation of 2-indolinone derivatives as PAK1 inhibitors in MDA-MB-231 cells
    Yao, Dahong
    Ruhan, A.
    Jiang, Jin
    Huang, Jian
    Wang, Jinhui
    Han, Weina
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (17)
  • [9] Design, synthesis, in vivo and in vitro studies of 1,2,3,4-tetrahydro-9H-carbazole derivatives, highly selective and potent butyrylcholinesterase inhibitors
    Ghobadian, Roshanak
    Esfandyari, Roghaieh
    Nadri, Hamid
    Moradi, Alireza
    Mahdavi, Mohammad
    Akbarzadeh, Tahmineh
    Khaleghzadeh-Ahangar, Hossein
    Edraki, Najmeh
    Sharifzadeh, Mohammad
    Amini, Mohsen
    MOLECULAR DIVERSITY, 2020, 24 (01) : 211 - 223
  • [10] Design, synthesis, and bioevaluation of imidazo [1,2-a] pyrazine derivatives as tubulin polymerization inhibitors with potent anticancer activities
    Deng, Bulian
    Sun, Zhiqiang
    Wang, Yuxi
    Mai, Ruiyao
    Yang, Zichao
    Ren, Yichang
    Liu, Jin
    Huang, Junli
    Ma, Zeli
    Chen, Ting
    Zeng, Canjun
    Chen, Jianjun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 76